PERCEPTIONS OF OLDER ADULTS ON THE USE OF AN INTERACTIVE VIDEO GAME IN PROMOTING HEALTH AND WELL-BEING



The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter

Palbociclib was approved by the United States Food and Drug Administration for use, in combination with letrozole, as a first-line treatment for estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) postmenopausal metastatic breast read more cancer.However, recent studies show that palbociclib may be an inhibitor

read more